Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Ilomedin
Active Ingredient(s): Iloprost trometamol 134µg/mL equivalent to 100µg Iloprost/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Schering (NZ) Limited
Manufacturer(s): Schering AG, Wedding Plant, Berlin, Germany
Product: WinRho SDF
Active Ingredient(s): Anti-D (Rho) immunoglobulin 600IU equivalent to 120µg
Dosage Form: Powder for injection
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Cangene Corporation, Winnipeg, Manitoba, Canada
Dated this 18th day of September 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).